WallStSmart

Crowdstrike Holdings Inc (CRWD)vsUipath Inc (PATH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Crowdstrike Holdings Inc generates 205% more annual revenue ($5.09B vs $1.67B). PATH leads profitability with a 19.6% profit margin vs -0.6%. PATH appears more attractively valued with a PEG of 0.38. PATH earns a higher WallStSmart Score of 71/100 (B).

CRWD

Hold

39

out of 100

Grade: F

Growth: 9.3Profit: 2.0Value: 3.0Quality: 6.0
Piotroski: 2/9Altman Z: 1.00

PATH

Strong Buy

71

out of 100

Grade: B

Growth: 8.7Profit: 6.0Value: 7.7Quality: 7.5
Piotroski: 5/9Altman Z: 1.50
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CRWDSignificantly Overvalued (-72.9%)

Margin of Safety

-72.9%

Fair Value

$396.04

Current Price

$671.02

$274.98 premium

UndervaluedFair: $396.04Overvalued

Intrinsic value data unavailable for PATH.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRWD4 strengths · Avg: 9.0/10
EPS GrowthGrowth
533.0%10/10

Earnings expanding 533.0% YoY

Market CapQuality
$176.39B9/10

Large-cap with strong market position

Debt/EquityHealth
0.189/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
25.6%8/10

Revenue surging 25.6% year-over-year

PATH6 strengths · Avg: 9.0/10
PEG RatioValuation
0.3810/10

Growing faster than its price suggests

EPS GrowthGrowth
105.7%10/10

Earnings expanding 105.7% YoY

Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

P/E RatioValuation
17.6x8/10

Attractively priced relative to earnings

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
17.3%8/10

17.3% revenue growth

Areas to Watch

CRWD4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
5.642/10

Expensive relative to growth rate

Price/BookValuation
36.9x2/10

Trading at 36.9x book value

Return on EquityProfitability
-0.5%2/10

ROE of -0.5% — below average capital efficiency

PATH1 concerns · Avg: 4.0/10
Altman Z-ScoreHealth
1.504/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CRWD

The strongest argument for CRWD centers on EPS Growth, Market Cap, Debt/Equity. Revenue growth of 25.6% demonstrates continued momentum.

Bull Case : PATH

The strongest argument for PATH centers on PEG Ratio, EPS Growth, Debt/Equity. Profitability is solid with margins at 19.6% and operating margin at 7.3%. Revenue growth of 17.3% demonstrates continued momentum.

Bear Case : CRWD

The primary concerns for CRWD are Piotroski F-Score, PEG Ratio, Price/Book.

Bear Case : PATH

The primary concerns for PATH are Altman Z-Score.

Key Dynamics to Monitor

CRWD carries more volatility with a beta of 1.24 — expect wider price swings.

CRWD is growing revenue faster at 25.6% — sustainability is the question.

CRWD generates stronger free cash flow (493M), providing more financial flexibility.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

PATH scores higher overall (71/100 vs 39/100), backed by strong 19.6% margins and 17.3% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Crowdstrike Holdings Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

CrowdStrike Holdings, Inc. provides cloud solutions for endpoint and cloud workload protection in the United States, Australia, Germany, India, Israel, Romania, and the United Kingdom. The company is headquartered in Sunnyvale, California.

Visit Website →

Uipath Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

UiPath Inc. provides an end-to-end automation platform offering a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company is headquartered in New York, New York.

Visit Website →

Want to dig deeper into these stocks?